REVEAL-CKD: EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN CHINA

https://storage.unitedwebnetwork.com/files/1099/aca4e1014cf3a88aa7f8a44ee95fa95c.pdf
REVEAL-CKD: EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN CHINA
Claudia
Cabrera
Shiyu Zhou zsygaza@163.com National Clinical Research Center for Kidney Disease Division of Nephrology Guangzhou
Mengyun Jia emily.jia@astrazeneca.com AstraZeneca Pharmaceutical (Hangzhou) Co. Ltd. Medical Affairs CVRM Hangzhou
Shiyu Zhang shiyu.zhang1@astrazeneca.com AstraZeneca Investment (China) Co.,Ltd Biostatistics, Evidence Shanghai
Licong Su slc666@smu.edu.cn National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University Division of Nephrology Guangzhou
Qi Gao qigao_97@163.com National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University Division of Nephrology Guangzhou
Sheng Nie niesheng0202@126.com National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University Division of Nephrology Guangzhou